Michiel van Speybroeck
Technik-/Wissenschafts-/F&E-Leiter bei FORMAC Pharmaceuticals NV
Profil
Michiel van Speybroeck is currently the Director of Research & Development at FORMAC Pharmaceuticals NV since 2012.
He previously worked as a Principal at Monash Institute of Medical Research.
He obtained a doctorate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Michiel van Speybroeck
| Unternehmen | Position | Beginn |
|---|---|---|
FORMAC Pharmaceuticals NV
 FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Ehemalige bekannte Positionen von Michiel van Speybroeck
| Unternehmen | Position | Ende |
|---|---|---|
| Monash Institute of Medical Research | Corporate Officer/Principal | - |
Ausbildung von Michiel van Speybroeck
| Katholieke Universiteit Leuven | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | Health Technology |
| Monash Institute of Medical Research |
